Who invested in ARRIVENT?
4 investors are on record as having backed ARRIVENT — Develops biopharmaceutical products for unmet needs, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
arrivent.comARRIVENT investors
Catalio Capital Management, LPInvests across innovative healthcare's full lifecycle, leveraging a network of…Jan 2024their site
HBM Partners Hong Kong LimitedBacks biopharma, medtech, diagnostics and healthcare companies from venture to buy-out…$155MMar 2023press
2 more investors on record for ARRIVENT.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed ARRIVENT are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.